fig1

Curcumin sensitizes quiescent leukemic cells to antimitotic drug 5-fluorouracil by inducing proliferative responses in them

Figure 1. QLCs undergo proliferation in response to low concentrations of curcumin: Serum-starved KG1a cells were treated with varying concentrations of curcumin (10-100 µg/mL) for 48 h and were subjected to MTT assay. Treatment with low concentrations (10 µg/mL and 20 µg/mL) of curcumin led to proliferation of QLC cells as compared to the vehicle control (VC) cells. The data represent mean ± S.E.M. of three independent experiments (*** P ≤ 0.001)

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/